Van- JPMorgan says own these medical device stocks into next week's conference 07:41 BSX, INSP, ABT, EW, PEN, ATRC, DXCM Into his firm's healthcare conference next week, JPMorgan analyst Robbie Marcus recommends owning medical device stocks that either likely won't be preannouncing "but can still talk to a bullish long-term outlook," or stocks that could preannounce a Q4 beat off "appropriately conservative expectations." For the former, Marcus recommends Boston Scientific (BSX), Inspire Medical (INSP), Abbott (ABT), Edwards Lifesciences (EW) and Penumbra (PEN). For the latter, Marcus recommends AtriCure (ATRC) and DexCom (DXCM), though he notes that DexCom "will probably guide very conservatively" to 15%-20% growth in 2021.
THE SAVANT HERE. How is everyone doing? There is a stock that is prime to be bought RIGHT NOW! Value is in the eye of the beholder. So with much of Danny Meyer's places closing again we still have Shake Shack. That's value. A great burger. Value again. A meal for under $50 Value Value Value! YOUR SAVANT STOCK OF THE WEEK- Shake Shack Inc. (SHAK) @ $71.50 GBA Upgrade To Buy*** NYSE - NYSE Delayed Price. Currency in USD 70.26-3.05 (-4.16%) At close: 04:00PM EST 71.50 +1.24 (+1.76%) After hours: 07:08PM EST
Stoney lol.... I wasn't trying to lie, it was this morning when I brought up the discussion of SNAP, you said go with the Robo. It was just under $94 at the time. 11:15 Eastern. Here: But whatever. On the options, time is on their side in the sense that time marches on. If it stays at $42 all else being equal, the value of those puts they SOLD drops. Note... they SOLD those puts. They got $8.15 for them today. Now if SNAP goes to whatever.... say $47 anytime soon, those puts will be trading at a value less than $8.15... so they could just buy them back, and close the position. They are SHORT those puts. It's a bullish bet. At some point they buy them back or they ride it out. The higher SNAP goes, the cheaper it is for them to buy them back. If it goes up, perhaps in a few weeks those puts will be worth only $7.15. Sell for $8.15 and buy back for $7.15. You make $1/share X 100 X 26,500 to close the position early. $2.65M.
Stoney, guess which stock hit an all time today... Smuckers. $141 Hey I have another gem I posted in my "Winning Stocks" thread. Adobe at $514. It'll be another VZ 10% winner in less than 2 months tops. Possibly 2 weeks. Possibly my best pick yet.
I told you man. JIF peanut butter for the win. Best tasting stuff. There really are choosy moms out there, hehe. Damnit, I so wish I had more money to trade with, because what you guys do seems so much more fun and engaging. Interacting with individual stocks based on the fundies...Man, it seems more exciting. GAH!
GOOD MORNING EVERYONE. There was an article in the Times That the Covid tests are not working with Omicrom. I knew this when my bro gave me the Mylie Cyrus story about the two lines of people and one whole line positive and one whole line negative. It seems the better tests are the saliva test like what OSUR has. Is ABT's saliva or up the nose. Up the nose not working as well... " ALL THE NEWS THAT FIT TO GUMMY "- tm Nike suing Lulu- Lululemon tells CNBC Nike patents in question 'overly broad and invalid' 15:47 LULU, NKE Following the report that Nike (NKE) filed a lawsuit accusing Lululemon (LULU) of patent infringement over the at-home Mirror fitness device and related mobile applications, Lululemon responded in a statement to CNBC that "The patents in question are overly broad and invalid. We are confident in our position and look forward to defending it in court," according to CNBC's Lauren Thomas. Mirror Device-? Nike lawsuit claims Lululemon infringed patents with Mirror device, CNBC says 15:31 LULU, NKE Nike (NKE) filed a lawsuit in Manhattan federal court alleging Lululemon (LULU) infringed on its patents with the at-home Mirror fitness device and corresponding mobile apps, Lauren Thomas of CNBC reported. Lululemon shares were down in afternoon trading. Lululemon previously dismissed Nike's concerns ahead of the suit being filed, according to Nike. Reference Link Sector Move Wells Fargo - Okta initiated with an Overweight at Wells Fargo 16:09 OKTA Wells Fargo analyst Andrew Nowinski initiated coverage of Okta with an Overweight rating and $275 price target. Wells starts Okta at Overweight on 'most comprehensive' platform 16:17 OKTA As previously reported, Wells Fargo analyst Andrew Nowinski initiated coverage of Okta with an Overweight rating and $275 price target, citing his belief that Okta has assembled "the most comprehensive identity security platform in the market." He thinks this should enable growth to remain at or above 35% for the foreseeable future given his view that "no other vendor has a cloud-based platform designed for securing modern-day applications that covers all elements of identity security." Zscaler initiated with an Overweight at Wells Fargo 16:13 ZS Wells Fargo analyst Andrew Nowinski initiated coverage of Zscaler with an Overweight rating and $400 price target. The volume and sophistication of cyber attack's is increasing "at an alarming rate," said Nowinski, who argues that Zscaler has "the most sophisticated Zero Trust platform in the market" at a time when the only way to effectively defend against an attack is to deploy a Zero Trust architecture. Valuation appears expensive relative to peers, but he believe Zscaler's competitive advantages are sustainable, the analyst added. Wells starts Crowdstrike at Overweight, names as top pick for 2022 16:22 CRWD As previously reported, Wells Fargo analyst Andrew Nowinski initiated coverage of Crowdstrike with an Overweight rating and $275 price target. The analyst, who sees CrowdStrike being well-positioned to continue to take share from both legacy and next-gen vendors with "one of the most comprehensive platforms in the industry," also named the stock as a top pick for 2022. He calls ARR "the most important metric to measure the health of CrowdStrike" and the success of its new modules, adding that he believes the Street is not factoring in enough of a contribution from the new products and modules, which results in ARR being "largely" underestimated in the consensus view. RealReal reports December GMV $153M, up 40% y/y, to resume quarterly updates 16:19 REAL The RealReal provided a business update. December gross merchandise value, GMV, was approximately $153M, an increase of 40% and 49% compared to the same periods in 2020 and 2019, respectively. December average order value, AOV, was approximately $518, an increase of 10% and 4% compared to the same periods in 2020 and 2019, respectively. Watches, Women's Shoes and Women's Apparel were the fastest growing categories in December. The RealReal believed that disclosing monthly GMV and AOV provided additional transparency regarding the effects of the COVID-19 pandemic on its business. Consistent with SEC guidance regarding the impacts of the COVID-19 pandemic, the company provided monthly GMV and AOV through the end of 2021. The company plans to return to a more typical quarterly and annual guidance cadence in 2022 and will no longer provide monthly business updates going forward. Granite selected for $90M construction project in California 17:31 GVA Granite announced that it has been selected by the California Department of Transportation as the Construction Manager/General Contractor for the approximately $90M State Route 70 Binney Junction Roadway Rehabilitation and Complete Streets CM/GC project. In the first phase of this project, valued at $1.3 million, Granite will work closely with Caltrans and project designers on the design, constructability, and cost estimating portions of the project. The Construction Management portion of the Binney Junction project is expected to begin in Q1, 2022 and the General Contractor phase is expected to begin in Q1, 2023. GVA $38.84 It's done pretty well but slow. We have some in the early $30's. I sold a bunch out of boredom. PlayStation exclusive 'Ghost of Tsushima' sells over 8M copies 17:47 SONY Sucker Punch, a Sony-owned video game developer, said in a tweet last night that its 2020 game "Ghost of Tsushima," which first launched on PlayStation 4 before receiving a PlayStation 5 remaster this year, has sold over 8M copies. Allbirds upgraded to Overweight from Equal Weight at Morgan Stanley 05:29 BIRD Darktrace upgraded to Overweight from Neutral at Piper Sandler 06:02 DRKTF Piper Sandler analyst Rob Owens upgraded Darktrace to Overweight from Neutral with a price target of 600 GBp, down from 900 GBp. Many of the demand drivers that positively impacted cybersecurity spending in 2021 remain in play as we enter 2022, Owens tells investors in a research note. Add to that a "relatively optimistic" IT spending outlook with security prioritization forecasted to continue in 2022, and the "perfect storm" for increased cybersecurity demand will sustain, says the analyst. He upgraded Darktrace to reflect the "robust threat landscape." Global Payments shares 'undervalued for solid growth,' says Deutsche Bank 06:15 GPN Deutsche Bank Global Payments confident in mid-cycle guidance, says Susquehanna 07:03 GPN Avantor named 2022 top pick at UBS 06:29 AVTR UBS analyst John Sourbeer keeps his Buy rating and $50 price target on Avantor as part of a broader research note on Life Sciences & Diagnostic Tools. The analyst sees upward bias to results driven by continued strong biotech demand and base recoveries for the group, adding that while macro pressures remain on the radar, these are reflected in guidance and consensus. Sourbeer further states that Avantor offers valuation that is attractive at current levels with better accelerating growth stories heading into 2022. Lululemon recent pullback brings compelling entry point, says Baird 06:34 LULU Baird analyst Mark Altschwager said the recent pullback in Lululemon brings a compelling entry point for investors. The analyst said he anticipates an upward FQ4 guidance revision ahead of ICR and notes shares are compelling with current valuation at the lower end of the multi-year range. Altschwager reiterated his Outperform rating and $500 price target on Lululemon shares. Boeing MAX order starts year off right, says Susquehanna 07:00 BA Canada Goose upgraded to Overweight from Equal Weight at Barclays 07:07 GOOS Curis' CA-4948 monotherapy shows positive activity in Phase 1/2 AML study 07:13 CRIS MGM Resorts price target raised to $74 from $68 at Credit Suisse 08:08 MGM Walmart may be having better winter than expected, MKM Partners 08:08 WMT Royal Caribbean cancels Spectrum of the Seas trip amid COVID surge, Reuters says ยป